News
ARAY
2.240
0.00%
0.000
Accuray Appoints Leonel Peralta as COO
TipRanks · 1d ago
Accuray names Leonel Peralta as COO
TipRanks · 1d ago
Accuray Announces Leonel Peralta Is Joining The Company As Senior Vice President, Chief Operations Officer, Effective February 3, 2025
Benzinga · 1d ago
LEONEL PERALTA TO JOIN ACCURAY AS CHIEF OPERATIONS OFFICER
Reuters · 1d ago
Press Release: Leonel Peralta to Join Accuray as Chief Operations Officer
Dow Jones · 1d ago
TMDX Stock Down Despite Responding to Misleading Short-Seller Report
NASDAQ · 2d ago
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now
NASDAQ · 2d ago
Weekly Report: what happened at ARAY last week (0113-0117)?
Weekly Report · 2d ago
Reasons to Add GE HealthCare Stock to Your Portfolio Now
NASDAQ · 5d ago
GEHC Stock Gains on Long-Term Collaboration With Sutter Health
NASDAQ · 5d ago
Intuitive Surgical Stock Surges on Q4 Preliminary Revenue Beat
NASDAQ · 6d ago
PACB Stock Declines Despite Promising HiFi Sequencing Findings
NASDAQ · 01/15 17:20
ARAY Stock Gains as China Approves Latest Radiation Therapy Solutions
NASDAQ · 01/14 17:13
Lake Street Sticks to Their Buy Rating for Accuray (ARAY)
TipRanks · 01/14 13:55
DexCom Stock Up Following Strong Preliminary Q4 Results & 2025 Outlook
NASDAQ · 01/14 13:11
TEM Stock Declines Following Preliminary Q4 Sales Miss
NASDAQ · 01/14 13:09
Accuray announces Radixact SynC and CyberKnife S7 approved by China’s NMPA
TipRanks · 01/13 20:10
ACCURAY: RADIXACT SYNC SYSTEM & CYBERKNIFE S7 SYSTEM APPROVED BY CHINESE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Reuters · 01/13 20:03
PacBio Stock May Gain Following the Collaborated Launch of GutID
NASDAQ · 01/13 16:11
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
NASDAQ · 01/13 13:23
More
Webull provides a variety of real-time ARAY stock news. You can receive the latest news about Accuray Incorp through multiple platforms. This information may help you make smarter investment decisions.
About ARAY
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.